13F-HR filed by Commodore Capital LP
Commodore Capital LP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 35 holding rows worth $663,544,000.
- Accession
- 0001831942-23-000005
- Filer
- CIK 1831942
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 35 entries on the cover page, a total value of $663,544,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $663,544,000 with VALUE read as thousands, detected and multiplied, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,659,111 | $65,419,000 | thousands, detected and multiplied | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 2,020,166 | $59,009,000 | thousands, detected and multiplied | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 4,319,940 | $49,939,000 | thousands, detected and multiplied | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 5,303,557 | $43,595,000 | thousands, detected and multiplied | |
| MERUS N V | N5749R100 | COM | 2,732,567 | $42,273,000 | thousands, detected and multiplied | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 5,738,500 | $35,980,000 | thousands, detected and multiplied | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,880,286 | $29,615,000 | thousands, detected and multiplied | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 537,076 | $29,432,000 | thousands, detected and multiplied | |
| NUVALENT INC COM | 670703107 | Stock | 913,621 | $27,208,000 | thousands, detected and multiplied | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 495,823 | $22,099,000 | thousands, detected and multiplied | |
| IMMUNOVANT INC | 45258J102 | COM | 1,150,505 | $20,421,000 | thousands, detected and multiplied | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 462,111 | $18,743,000 | thousands, detected and multiplied | |
| CELCUITY INC | 15102K100 | COM | 1,327,952 | $18,605,000 | thousands, detected and multiplied | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 591,437 | $18,323,000 | thousands, detected and multiplied | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 688,445 | $17,521,000 | thousands, detected and multiplied | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 739,661 | $15,918,000 | thousands, detected and multiplied | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 127,156 | $13,987,000 | thousands, detected and multiplied | |
| ALLAKOS INC | 01671P100 | COM | 1,643,500 | $13,838,000 | thousands, detected and multiplied | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,099,407 | $13,644,000 | thousands, detected and multiplied | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 598,385 | $13,290,000 | thousands, detected and multiplied | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 590,705 | $13,108,000 | thousands, detected and multiplied | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 223,494 | $10,397,000 | thousands, detected and multiplied | |
| IMARA INC | 45249V107 | COM | 2,494,794 | $10,204,000 | thousands, detected and multiplied | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 1,325,000 | $9,739,000 | thousands, detected and multiplied | |
| 89BIO INC | 282559103 | COM | 758,244 | $9,652,000 | thousands, detected and multiplied | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,010,359 | $9,346,000 | thousands, detected and multiplied | |
| VAXCYTE INC COM | 92243G108 | Stock | 173,481 | $8,318,000 | thousands, detected and multiplied | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 1,935,609 | $6,581,000 | thousands, detected and multiplied | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 993,294 | $4,271,000 | thousands, detected and multiplied | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 750,000 | $3,098,000 | thousands, detected and multiplied | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 498,315 | $2,691,000 | thousands, detected and multiplied | |
| IMMUNIC INC | 4525EP101 | COM | 1,800,000 | $2,520,000 | thousands, detected and multiplied | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,210,000 | $2,505,000 | thousands, detected and multiplied | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 312,553 | $2,113,000 | thousands, detected and multiplied | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 92,687 | $142,000 | thousands, detected and multiplied |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001831942-23-000005 | this filing | 2023-02-14 | acceptance time not in the bulk data set |